XML 26 R6.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Noncontrolling Interest in Subsidiary
Beginning Balance (in shares) at Dec. 31, 2017   35,838,000        
Beginning Balance at Dec. 31, 2017 $ 237,719 $ 4 $ 305,362 $ (1,166) $ (67,111) $ 630
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of share options (in shares)   21,000        
Vesting of restricted stock and performance stock awards (in shares)   199,000        
Vesting of restricted stock (889)   (889)      
Equity compensation $ 3,575   3,575      
Stock repurchase and retirement (in shares) (432,000) (432,439)        
Stock repurchase and retirement $ (5,000) $ (5,000)        
Foreign currency translation adjustment, net of taxes (121)     (121)    
Net change in hedging transaction, net of taxes (175)     (175)    
Distribution to noncontrolling shareholder (1,194)         (1,194)
Net (loss) income (15,717)       (16,951) 1,234
Ending Balance (in shares) at Dec. 31, 2018   35,626,000        
Ending Balance at Dec. 31, 2018 218,198 $ 4 303,048 (1,462) (84,062) 670
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of share options (in shares)   14,000        
Vesting of restricted stock and performance stock awards (in shares)   231,000        
Vesting of restricted stock (801)   (801)      
Equity compensation 3,396   3,396      
Stock repurchase and retirement (in shares)   0        
Foreign currency translation adjustment, net of taxes 47     47    
Net change in hedging transaction, net of taxes 175     175    
Distribution to noncontrolling shareholder (1,572)         (1,572)
Net (loss) income (55,943)       (57,713) 1,770
Ending Balance (in shares) at Dec. 31, 2019   35,871,000        
Ending Balance at Dec. 31, 2019 $ 163,500 $ 4 305,643 (1,240) (141,775) 868
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of share options (in shares) 1,000          
Vesting of restricted stock and performance stock awards (in shares)   306,000        
Vesting of restricted stock $ (658)   (658)      
Equity compensation 5,403   5,403      
Stock repurchase and retirement (in shares)   0        
Foreign currency translation adjustment, net of taxes (40)     (40)    
Distribution to noncontrolling shareholder (1,154)         (1,154)
Net (loss) income (12,142)       (12,962) 820
Ending Balance (in shares) at Dec. 31, 2020   36,177,000        
Ending Balance at Dec. 31, 2020 $ 154,909 $ 4 $ 310,388 $ (1,280) $ (154,737) $ 534